financetom
Business
financetom
/
Business
/
Mazagon Dock targets Rs 5,000 cr revenue in FY22, eyes 10-15% topline growth in FY23
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mazagon Dock targets Rs 5,000 cr revenue in FY22, eyes 10-15% topline growth in FY23
Dec 13, 2021 2:34 AM

In an interview with CNBC-TV18, Sanjeev Singhal, Director Finance at Mazagon Dock Shipbuilders talked about their business outlook.

On FY22 revenues Singhal said they are targeting revenues around Rs 5,000 crore and 10-15 percent growth in 22-23.

On EBITDA margins he said, “My order book consists of the nomination based orders so there won’t be a significant change in terms of EBITDA margin, although the volume is going up in absolute numbers, definitely numbers will be rising.”

For full management commentary, watch the video.

First Published:Dec 13, 2021 11:34 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Jan 16, 2025
Katapult Holdings Inc ( KPLT ) shares are trading higher by 63% to $11.41 during Thursday’s session after the company reported $75.2 million in gross originations for the fourth quarter of 2024, up 11.3% year-over-year and surpassing its November forecast of 6-8% growth. What To Know: Katapult ( KPLT ) says this marks the ninth consecutive quarter of annual growth...
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Jan 16, 2025
(Reuters) -Citigroup ( C/PN ) is cutting more jobs this week to meet CEO Jane Fraser's expense goals, Bloomberg News reported on Thursday, citing people familiar with the matter.  Managing directors in the wealth and technology units are leaving the firm and Citi is also axing people from a team that compiles data and analysis on the bank's clients, according...
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
Jan 16, 2025
02:17 PM EST, 01/16/2025 (MT Newswires) -- Omeros ( OMER ) said Thursday that results from a statistical analysis of narsoplimab, its monoclonal antibody to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, showed robustness of the previously reported primary endpoint analysis. The company said that newly completed sensitivity analyses confirm the survival benefit of narsoplimab in patients with...
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Jan 16, 2025
02:18 PM EST, 01/16/2025 (MT Newswires) -- Issuer Direct ( ISDR ) said Thursday it will change its name to ACCESS Newswire and trade under the new ticker ACCS on the NYSE American Exchange, effective Jan. 27. No action is required by stockholders with respect to the changes, the company said. Price: 9.00, Change: +0.14, Percent Change: +1.58 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved